Rare germline copy number variants (CNVs) and breast cancer risk.

Dennis J., Tyrer JP., Walker LC., Michailidou K., Dorling L., Bolla MK., Wang Q., Ahearn TU., Andrulis IL., Anton-Culver H., Antonenkova NN., Arndt V., Aronson KJ., Freeman LEB., Beckmann MW., Behrens S., Benitez J., Bermisheva M., Bogdanova NV., Bojesen SE., Brenner H., Castelao JE., Chang-Claude J., Chenevix-Trench G., Clarke CL., NBCS Collaborators None., Collée JM., CTS Consortium None., Couch FJ., Cox A., Cross SS., Czene K., Devilee P., Dörk T., Dossus L., Eliassen AH., Eriksson M., Evans DG., Fasching PA., Figueroa J., Fletcher O., Flyger H., Fritschi L., Gabrielson M., Gago-Dominguez M., García-Closas M., Giles GG., González-Neira A., Guénel P., Hahnen E., Haiman CA., Hall P., Hollestelle A., Hoppe R., Hopper JL., Howell A., ABCTB Investigators None., kConFab/AOCS Investigators None., Jager A., Jakubowska A., John EM., Johnson N., Jones ME., Jung A., Kaaks R., Keeman R., Khusnutdinova E., Kitahara CM., Ko Y-D., Kosma V-M., Koutros S., Kraft P., Kristensen VN., Kubelka-Sabit K., Kurian AW., Lacey JV., Lambrechts D., Larson NL., Linet M., Ogrodniczak A., Mannermaa A., Manoukian S., Margolin S., Mavroudis D., Milne RL., Muranen TA., Murphy RA., Nevanlinna H., Olson JE., Olsson H., Park-Simon T-W., Perou CM., Peterlongo P., Plaseska-Karanfilska D., Pylkäs K., Rennert G., Saloustros E., Sandler DP., Sawyer EJ., Schmidt MK., Schmutzler RK., Shibli R., Smeets A., Soucy P., Southey MC., Swerdlow AJ., Tamimi RM., Taylor JA., Teras LR., Terry MB., Tomlinson I., Troester MA., Truong T., Vachon CM., Wendt C., Winqvist R., Wolk A., Yang XR., Zheng W., Ziogas A., Simard J., Dunning AM., Pharoah PDP., Easton DF.